Completed PHASE2 INTERVENTIONAL 2-arm NCT01976806

The Effects of DHA on Periodontitis (DAP)

The Effects of Docosahexaenoic Acid on Periodontitis in Adults: A Pilot Randomized Controlled Trial

Sponsor: Beth Israel Deaconess Medical Center

Conditions Gingivitis Inflammation Periodontitis

Interventions Aspirin Docosahexaenoic acid Placebo (for Docosahexaenoic acid)

Updated 6 times since 2017 Last updated: Nov 17, 2017 Started: Jun 30, 2009 Primary completion: Sep 30, 2011 Completion: Sep 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Gingivitis and Inflammation, this trial is completed. The trial is conducted by Beth Israel Deaconess Medical Center and has accumulated 6 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2022 — Jul 2024 [monthly]

Completed PHASE2
Jan 2021 — Jan 2022 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Jun 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Beth Israel Deaconess Medical Center
Harvard Medical School (HMS and HSDM)
National Center for Research Resources (NCRR)

Data source: Beth Israel Deaconess Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Boston, United States